Cargando…

Impact of low-level viremia with drug resistance on CD4 cell counts among people living with HIV on antiretroviral treatment in China

BACKGROUND: Maintaining plasma HIV RNA suppression below the limit of quantification is the goal of antiretroviral therapy (ART). When viral loads (VL) remain in low-level viremia (LLV), or between 201 and 999 copies/mL, the clinical consequences are still not clear. We investigated the occurrence o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Pengtao, You, Yinghui, Liao, Lingjie, Feng, Yi, Shao, Yiming, Xing, Hui, Lan, Guanghua, Li, Jianjun, Ruan, Yuhua, Li, Dan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066819/ https://www.ncbi.nlm.nih.gov/pubmed/35509014 http://dx.doi.org/10.1186/s12879-022-07417-z

Ejemplares similares

Effects of HIV-1 genotype on baseline CD4+ cell count and mortality before and after antiretroviral therapy
por: Cao, Zhiqiang, et al.
Publicado: (2020)

Early antiretroviral therapy on reducing HIV transmission in China: strengths, weaknesses and next focus of the program
por: Liu, Pengtao, et al.
Publicado: (2018)

Effects of high CD4 cell counts on death and attrition among HIV patients receiving antiretroviral treatment: an observational cohort study
por: Tang, Zhenzhu, et al.
Publicado: (2017)

Adherence, virological outcome, and drug resistance in Chinese HIV patients receiving first-line antiretroviral therapy from 2011 to 2015
por: Liu, Pengtao, et al.
Publicado: (2018)

Polymorphisms and Mutational Covariation Associated with Death in a Prospective Cohort of HIV/AIDS Patients Receiving Long-Term ART in China
por: Liu, Pengtao, et al.
Publicado: (2017)

HIV transmission and associated factors under the scale-up of HIV antiretroviral therapy: a population-based longitudinal molecular network study
por: Chen, Yi, et al.
Publicado: (2023)

Relationship Between Drug Resistance and Death in HIV-Infected Patients Receiving Antiretroviral Therapy — 7 PLADs, China, 2010−2019
por: Zhang, Tianhao, et al.
Publicado: (2021)

Genetic network analysis of human immunodeficiency virus sexual transmission in rural Southwest China after the expansion of antiretroviral therapy: A population-based study
por: Chen, Jin, et al.
Publicado: (2022)

Treatment outcomes of initial differential antiretroviral regimens among HIV patients in Southwest China: comparison from an observational cohort study
por: Kang, Ruihua, et al.
Publicado: (2019)

HIV drug resistance in patients in China’s national HIV treatment programme who have been on first-line ART for at least 9 months
por: Liu, Pengtao, et al.
Publicado: (2020)

Factors associated with viremia in people living with HIV on antiretroviral therapy in Guatemala
por: Ortíz, Dean W., et al.
Publicado: (2021)

Treatment outcomes and HIV drug resistance of patients switching to second-line regimens after long-term first-line antiretroviral therapy: An observational cohort study
por: Cao, Pi, et al.
Publicado: (2018)

Mortality and Attrition Rates within the First Year of Antiretroviral Therapy Initiation among People Living with HIV in Guangxi, China: An Observational Cohort Study
por: Zhu, Jinhui, et al.
Publicado: (2021)

Impact of HIV Pretreatment Drug Resistance on Virological Failure After One-Year Antiretroviral Therapy — China, 2018–2019
por: Li, Miaomiao, et al.
Publicado: (2022)

Drug Resistance and Virological Failure among HIV-Infected Patients after a Decade of Antiretroviral Treatment Expansion in Eight Provinces of China
por: Zuo, Zhongbao, et al.
Publicado: (2016)

Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008–2012: a prospective cohort study
por: Kan, Wei, et al.
Publicado: (2017)

Survey of pretreatment HIV drug resistance and the genetic transmission networks among HIV-positive individuals in southwestern China, 2014–2020
por: Xu, Xiaoshan, et al.
Publicado: (2021)

Prevalence of Transmitted HIV drug resistance in antiretroviral treatment naïve newly diagnosed individuals in China
por: Zhao, Shuai, et al.
Publicado: (2018)

HIV Drug Resistance Mutations Detection by Next-Generation Sequencing during Antiretroviral Therapy Interruption in China
por: Li, Miaomiao, et al.
Publicado: (2021)

Predictors of Viremia in Postpartum Women on Antiretroviral Therapy
por: Hoffman, Risa M., et al.
Publicado: (2020)

Benefits and limitations of different study designs for long‐acting antiretroviral therapy among people living with HIV with viremia
por: Gandhi, Monica, et al.
Publicado: (2023)

Impact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China
por: Liao, Lingjie, et al.
Publicado: (2013)

Treatment Outcomes of HIV Infected Children After Initiation of Antiretroviral Therapy in Southwest China: An Observational Cohort Study
por: Zeng, Xiaoliang, et al.
Publicado: (2022)

Treatment effects of the differential first-line antiretroviral regimens among HIV/HBV coinfected patients in southwest China: an observational study
por: Zhu, Jinhui, et al.
Publicado: (2019)

Incidence and Associated Factors of HIV Drug Resistance in Chinese HIV-Infected Patients Receiving Antiretroviral Treatment
por: Xing, Hui, et al.
Publicado: (2013)

Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment
por: Aamer, Hadega A., et al.
Publicado: (2020)

Immune reconstruction effectiveness of combination antiretroviral therapy for HIV-1 CRF01_AE cluster 1 and 2 infected individuals
por: Li, Kang, et al.
Publicado: (2021)

Impacts of HIV-1 Subtype Diversity on Long-Term Clinical Outcomes in Antiretroviral Therapy in Guangxi, China
por: Jiang, He, et al.
Publicado: (2022)

Persistent HIV-1 Viremia on Antiretroviral Therapy: Measurement and Mechanisms
por: Jacobs, Jana L., et al.
Publicado: (2019)

Molecular transmission network of pretreatment drug resistance among human immunodeficiency virus-positive individuals and the impact of virological failure on those who received antiretroviral therapy in China
por: Chen, Hongli, et al.
Publicado: (2022)

Survey of Pretreatment HIV Drug Resistance and Genetic Transmission Network Analysis Among HIV Patients in a High Drug-Use Area of Southwest China
por: Liu, Lei, et al.
Publicado: (2019)

The prevalence of CRF55_01B among HIV-1 strain and its connection with traffic development in China
por: Gan, Mengze, et al.
Publicado: (2021)

Spatiotemporal Patterns of CRF07_BC in China: A Population-Based Study of the HIV Strain With the Highest Infection Rates
por: Gan, Mengze, et al.
Publicado: (2022)

Role of Proviral HIV-1 DNA Genotyping for People Living with HIV (PLWH) Who Had Low-Level Viremia While Receiving Antiretroviral Therapy
por: Lv, Shiyun, et al.
Publicado: (2023)

Antiretroviral therapy (ART) management of Low-Level Viremia in Taiwan (ALLEVIATE)
por: Cheng, Chien-Yu, et al.
Publicado: (2014)

Reduced adherence to antiretroviral therapy is associated with residual low-level viremia
por: Maggiolo, Franco, et al.
Publicado: (2017)

Hepatitis B viremia in HIV-coinfected individuals under antiretroviral therapy
por: Weissmann, Leonardo, et al.
Publicado: (2019)

The development of drug resistance mutations K103N Y181C and G190A in long term Nevirapine-containing antiviral therapy
por: Wang, Yuncong, et al.
Publicado: (2014)

Lamivudine Concentration in Hair and Prediction of Virologic Failure and Drug Resistance among HIV Patients Receiving Free ART in China
por: Yan, Jing, et al.
Publicado: (2016)

Virological Outcomes and Drug Resistance in Chinese Patients after 12 Months of 3TC-Based First-Line Antiretroviral Treatment, 2011–2012
por: Wang, Jing, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_e32lgde9e8r92k2l6s5dvn79mi